☆ 4.8 Meeting Abstract

MAGELLAN-1, PART 2: GLECAPREVIR AND PIBRENTASVIR FOR 12 OR 16 WEEKS IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 AND PRIOR DIRECT-ACTING ANTIVIRAL TREATMENT FAILURE

GASTROENTEROLOGY (2017)

Get Full Text
Add to Collection

Journal

GASTROENTEROLOGY
Volume 152, Issue 5, Pages S1057-S1057

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/S0016-5085(17)33570-9

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.